Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond to traditional medications.

Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder.

In animal studies, boosting serotonin in the cells that line the gut reduced anxious and depressive-like behaviors without causing cognitive or gastrointestinal side effects. Most of us have ...

As far as scientists know, irritable bowel syndrome doesn't cause depression ... syndrome who aren’t depressed can get relief from antidepressants. The drugs can help block how the brain ...

In a statement, Neumora revealed that the KOASTAL-1 study missed its primary endpoint, with navacaprant failing to achieve a ...

A study by scientists from Rutgers University and Columbia University has found that adults with depression who started ...

Conclusion: Depression in youth is common and treatable and responds best to multimodal treatment combining patient and family education, cognitive behavioral therapy, and antidepressant medication.

A popular antidepressant, often known by the brand ... two major classes of medications used to treat clinical symptoms of depression and anxiety, along with SSRIs (selective serotonin reuptake ...